Personal information

No personal information available

Activities

Collapse all

Employment (1)

Central Hospital Kristianstad: Kristianstad, SE

2017-03-01 to present | Consultant (Infectious Diseases)
Employment
Source: Self-asserted source
Per Nived

Education and qualifications (3)

Lund University, Faculty of Medicine: Lund, SE

2015-10 to present | PhD student (Rheumatology)
Education
Source: Self-asserted source
Per Nived

Central Hospital Kristianstad: Kristianstad, SE

2010-01 to 2015-05 | Specialist training in infectious diseases (Infectious Diseases)
Education
Source: Self-asserted source
Per Nived

Lund University, Faculty of Medicine: Lund, SE

2001-09 to 2007-01 | M.D.
Education
Source: Self-asserted source
Per Nived

Works (4)

The impact of immunomodulating treatment on the immunogenicity of COVID-19 vaccines in patients with immune-mediated inflammatory rheumatic diseases compared to healthy controls. A Swedish nationwide study (COVID19-REUMA)

Vaccine
2023-05 | Journal article
DOI: 10.1016/j.vaccine.2023.03.065
Contributors: Martina Frodlund; Per Nived; Aikaterini Chatzidionysiou; Anna Södergren; Eva Klingberg; Anders Bengtsson; Monika Hansson; Sophie Olsson; Elisa Pin; Lars Klareskog et al.
Source: check_circle
Crossref

Methotrexate Treatment Suppresses Monocytes in Nonresponders to Pneumococcal Conjugate Vaccine in Rheumatoid Arthritis Patients

Journal of Immunology Research
2022-07-28 | Journal article
DOI: 10.1155/2022/7561661
Contributors: Evelina Elmér; Per Nived; Åsa Pettersson; Lillemor Skattum; Thomas Hellmark; Meliha C. Kapetanovic; Åsa C. M. Johansson; Dawei Cui
Source: check_circle
Crossref

Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients

Arthritis Research & Therapy
2020-12 | Journal article
DOI: 10.1186/s13075-020-2124-3
Contributors: Per Nived; Göran Jönsson; Bo Settergren; Jon Einarsson; Tor Olofsson; Charlotte Sværke Jørgensen; Lillemor Skattum; Meliha C. Kapetanovic
Source: check_circle
Crossref

Antibody response to 13-valent pneumococcal conjugate vaccine is not impaired in patients with rheumatoid arthritis or primary Sjögren’s syndrome without disease modifying treatment

BMC Rheumatology
2018-12 | Journal article
DOI: 10.1186/s41927-018-0019-6
Contributors: Per Nived; Tore Saxne; Pierre Geborek; Thomas Mandl; Lillemor Skattum; Meliha C. Kapetanovic
Source: check_circle
Crossref

Peer review (4 reviews for 2 publications/grants)

Review activity for Arthritis research & therapy. (2)
Review activity for Vaccine. (2)
How many people are using ORCID?